Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals

CA Legare, WM Raup-Konsavage, KE Vrana - Pharmacology, 2022 - karger.com
Background: There is a growing interest in the use of cannabis (and its extracts), as well as
CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is …

Cannabis and endometriosis: The roles of the gut microbiota and the endocannabinoid system

T Farooqi, DJ Bhuyan, M Low, J Sinclair… - Journal of Clinical …, 2023 - mdpi.com
Endometriosis, a chronic condition affecting around 10–14% of women, is challenging to
manage, due to its complex pathogenesis and limited treatment options. Research has …

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits

PSS Montagner, W Medeiros, LCR da Silva… - Frontiers in …, 2023 - frontiersin.org
Autism Spectrum Disorders (ASD) may significantly impact the well-being of patients and
their families. The therapeutic use of cannabis for ASD has gained interest due to its …

The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study

D Glickman, S Dalessio… - Inflammatory bowel …, 2024 - academic.oup.com
Background Cannabis use is common in inflammatory bowel disease (IBD). Recent studies
demonstrated that use of cannabis may relieve symptoms; however, it is still unclear how …

Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence

K Safi, J Sobieraj, M Błaszkiewicz, J Żyła, B Salata… - Biomedicines, 2024 - mdpi.com
In light of the current International Association for the Study of Pain (IASP) clinical practice
guidelines (CPGs) and the European Society for Medical Oncology (ESMO) guidelines, the …

High cannabigerol hemp extract moderates colitis and modulates the microbiome in an inflammatory bowel disease model

BD Anderson, DE Sepulveda, R Nachnani… - The Journal of …, 2024 - Elsevier
Cannabis sativa L. has a long history of medicinal use, particularly for gastrointestinal
diseases. Patients with inflammatory bowel disease (IBD) report using cannabis to manage …

Abdominal pain in inflammatory bowel disease: an evidence-based, multidisciplinary review

MD Coates, K Clarke, E Williams… - Crohn's & Colitis …, 2023 - academic.oup.com
Abdominal pain is one of the most common and impactful symptoms associated with
inflammatory bowel disease, including both Crohn's disease and ulcerative colitis. A great …

[HTML][HTML] Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review

MS Thu, BJ Campbell, N Hirankarn, T Nopsopon… - Biomedicine & …, 2025 - Elsevier
With legalisation of cannabis for both medicinal and recreational use expanding to more
world nations, grasping its effects on the human body is vital. The microbiome is critical to …

Metabolomics: the key to unraveling the role of the microbiome in visceral pain neurotransmission

A Shute, DG Bihan, IA Lewis, Y Nasser - Frontiers in Neuroscience, 2022 - frontiersin.org
Inflammatory bowel disease (IBD), comprising Crohn's disease and Ulcerative colitis, is a
relapsing and remitting disease of the gastrointestinal tract, presenting with chronic …

Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders

NA Lashgari, N Momeni Roudsari… - Current …, 2024 - benthamdirect.com
Background: Visceral hypersensitivity (VH) is an overreaction of the gastrointestinal (GI) tract
to various stimuli and is characterized by hyperalgesia and/or allodynia. VH contributes to …